is semaglutide available in us FDA Warns on Certain Forms of Compounded Generic Semaglutide in USA (2026):

Exploring Other Perspectives Some of the lowest ranked analysts were already cautious, assuming around US$3.1 billion of revenue and US$268.9 million of earnings by 2028, and this surprise GLP-1 driven loss may push their already more pessimistic view on regulatory and margin risks even further apart from more optimistic expectations.

So in a way, you can also think of it as a weight loss peptide

No reliance on terminal ileum receptors

247 YiY.LinC.PengX.ZhangM.WuJ.MengC.et al

Lothar Hennighausen (NIH, NIDDK) for providing Stat 5 floxed mice

The FDA recently warned consumers not to use Captomer or Captomer-250 by Thorne Research, which contained DMSA